An analysis of first-line regimens for H pylori eradication supports bismuth quadruple therapy as a cost-effective treatment and rifabutin triple therapy as a viable alternative.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/first-line-helicobacter-pylori-regimens-which-most-cost-2026a10003zc?src=rss
Author :
Publish date : 2026-02-09 11:09:00
Copyright for syndicated content belongs to the linked Source.
